
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunomodulatory properties of HDAC6 inhibitors in cancer diseases: New chances for sophisticated drug design and treatment optimization
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Seminars in Cell and Developmental Biology (2022) Vol. 154, pp. 286-294
Closed Access | Times Cited: 14
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Seminars in Cell and Developmental Biology (2022) Vol. 154, pp. 286-294
Closed Access | Times Cited: 14
Showing 14 citing articles:
HDAC-targeting epigenetic modulators for cancer immunotherapy
Binbin Cheng, Wei Pan, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116129-116129
Closed Access | Times Cited: 30
Binbin Cheng, Wei Pan, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116129-116129
Closed Access | Times Cited: 30
Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 6
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 6
Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy
Ruirui Wang, Xin Dong, Xiongjian Zhang, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 958-973
Open Access
Ruirui Wang, Xin Dong, Xiongjian Zhang, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 958-973
Open Access
HDAC6 as a therapeutic target for HPV E7-driven cervical cancer
Wei Jiang, Shanshan Liu, Li Fu
Genome Instability & Disease (2025)
Closed Access
Wei Jiang, Shanshan Liu, Li Fu
Genome Instability & Disease (2025)
Closed Access
The diphenylpyrimidine derivative as a novel HDAC6 inhibitor alleviates atopic dermatitis through anti-inflammatory effects facilitated via TLR4/MAPK, STAT3 and NF-κB pathways
Jinting Chen, Hao Qiu, Xin Ran, et al.
Bioorganic Chemistry (2025), pp. 108451-108451
Closed Access
Jinting Chen, Hao Qiu, Xin Ran, et al.
Bioorganic Chemistry (2025), pp. 108451-108451
Closed Access
Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Cancer Drug Resistance (2025)
Open Access
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Cancer Drug Resistance (2025)
Open Access
Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein–Protein Interactions
Leen Asaad, Benjamin Pepperrell, Emma McErlean, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1274-1274
Open Access
Leen Asaad, Benjamin Pepperrell, Emma McErlean, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1274-1274
Open Access
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer
Aya Ahmed Fathy, A. M. M. A. Allam, Ahmed K. ElHady, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Aya Ahmed Fathy, A. M. M. A. Allam, Ahmed K. ElHady, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment
Feifei Yang, Ting Hu, Jianquan Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114920-114920
Closed Access | Times Cited: 16
Feifei Yang, Ting Hu, Jianquan Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114920-114920
Closed Access | Times Cited: 16
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond
Martina Minisini, Massimo Mascaro, Claudio Brancolini
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Martina Minisini, Massimo Mascaro, Claudio Brancolini
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Tackling Triple Negative Breast Cancer with HDAC inhibitors: 6 is the isoform!
A Guadagni, Simona Barone, Antonella Ilenia Alfano, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116884-116884
Open Access | Times Cited: 1
A Guadagni, Simona Barone, Antonella Ilenia Alfano, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116884-116884
Open Access | Times Cited: 1
HDAC6 inhibition alleviates acute pulmonary embolism: a possible future therapeutic option
Tao Zhou, Di Jia, Jiahui Han, et al.
Folia Histochemica et Cytobiologica (2023) Vol. 61, Iss. 1, pp. 56-67
Open Access | Times Cited: 3
Tao Zhou, Di Jia, Jiahui Han, et al.
Folia Histochemica et Cytobiologica (2023) Vol. 61, Iss. 1, pp. 56-67
Open Access | Times Cited: 3
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia
Pauline Schneider, Priscilla Wander, Susan T.C.J.M. Arentsen-Peters, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13207-13207
Open Access | Times Cited: 2
Pauline Schneider, Priscilla Wander, Susan T.C.J.M. Arentsen-Peters, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13207-13207
Open Access | Times Cited: 2
Green Synthesis of Bimetallic Cu−Cd Nanoparticles and its Catalytic Activity in Pyrido [2,3‐d;6,5‐d] Dipyrimidine Derivatives
J. Kopperundevi, D. Ashokkumar, M. Gopalakrishnan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 35
Closed Access
J. Kopperundevi, D. Ashokkumar, M. Gopalakrishnan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 35
Closed Access
Epigenetic regulation of inflammation
Aamir Ahmad
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 165-166
Closed Access | Times Cited: 1
Aamir Ahmad
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 165-166
Closed Access | Times Cited: 1
Towards Unraveling the Puzzle of KMT2A-rearranged Infant Acute Lymphoblastic Leukemia
Pauline Schneider
(2023)
Open Access
Pauline Schneider
(2023)
Open Access